Low Occurrence of Tuberculosis Drug Resistance among Pulmonary Tuberculosis Patients from an Urban Setting, with a Long-Running DOTS Program in Zambia
Tuberculosis Research and Treatment · 2010
DOI: 10.1155/2010/938178 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tuberculosis Research and Treatment, 2010. Verfasst von Chanda Mulenga und 9 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Sciences Department, Tropical Diseases Research Centre, P.O. Box 71769, Ndola, Zambia. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Belgian Directorate-General for Development Cooperation.
Abstract (Originalsprache)
We set out to determine the levels of Mycobacterium tuberculosis resistance to first- and second-line TB drugs in an urban population in Zambia. Sputum samples were collected consecutively from all smear-positive, new and previously treated patients, from four diagnostic centres in Ndola between January and July 2006. Drug susceptibility testing was performed using the proportion method against four first- and two second-line TB drugs.
Results
Among 156 new cases, any resistance was observed to be 7.7%, monoresistance to isoniazid and rifampicin was 4.5% and 1.3%, respectively. Of 31 retreatment cases, any resistance was observed to be 16.1%, monoresistance to isoniazid and rifampicin was 3.3% for each drug, and one case of resistance to both isoniazid and rifampicin (multidrug resistance) was detected. No resistance to kanamycin or ofloxacin was detected.
Conclusion
Although not representative of the country, these results show low levels of drug resistance in a community with a long-standing DOTS experience. Resource constrained countries may reduce TB drug resistance by implementing community-based strategies that enhance treatment completion.
Autor:innen und Institutionen
- Biomedical Sciences Department, Tropical Diseases Research Centre, P.O. Box 71769, Ndola, Zambia.
Förderung
- Belgian Directorate-General for Development Cooperation
Zitieren
APA
Mulenga, C., Chonde, A., Bwalya, I. C., Kapata, N., Kakungu-Simpungwe, M., Docx, S., Fissette, K., Shamputa, I. C., Portaels, F., & Rigouts, L. (2010). Low Occurrence of Tuberculosis Drug Resistance among Pulmonary Tuberculosis Patients from an Urban Setting, with a Long-Running DOTS Program in Zambia. Tuberculosis Research and Treatment. https://doi.org/10.1155/2010/938178
Vancouver
Mulenga C, Chonde A, Bwalya IC, Kapata N, Kakungu-Simpungwe M, Docx S, et al. Low Occurrence of Tuberculosis Drug Resistance among Pulmonary Tuberculosis Patients from an Urban Setting, with a Long-Running DOTS Program in Zambia. Tuberculosis Research and Treatment. 2010. doi:10.1155/2010/938178
BibTeX
@article{Mulenga2010,
author = {Mulenga, Chanda and Chonde, Allan and Bwalya, Innocent C and Kapata, Nathan and Kakungu-Simpungwe, Mathilda and Docx, Sven and Fissette, Krista and Shamputa, Isdore Chola and Portaels, Françoise and Rigouts, Leen},
title = {Low Occurrence of Tuberculosis Drug Resistance among Pulmonary Tuberculosis Patients from an Urban Setting, with a Long-Running DOTS Program in Zambia},
journal = {Tuberculosis Research and Treatment},
year = {2010},
doi = {10.1155/2010/938178}
}
EUVIMED